These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12932897)

  • 1. Antagonists and agonists at the glycine site of the NMDA receptor for therapeutic interventions.
    Jansen M; Dannhardt G
    Eur J Med Chem; 2003; 38(7-8):661-70. PubMed ID: 12932897
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The glycine site on the NMDA receptor: structure-activity relationships and possible therapeutic applications.
    Dannhardt G; Kohl BK
    Curr Med Chem; 1998 Aug; 5(4):253-63. PubMed ID: 9668194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NMDA receptor antagonists and glycine site NMDA antagonists.
    Madden K
    Curr Med Res Opin; 2002; 18 Suppl 2():s27-31. PubMed ID: 12365826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by NMDA receptor antagonists in a variety of neuropathologies.
    Palmer GC
    Curr Drug Targets; 2001 Sep; 2(3):241-71. PubMed ID: 11554551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The NMDA receptor complex: a long and winding road to therapeutics.
    Wood PL
    IDrugs; 2005 Mar; 8(3):229-35. PubMed ID: 15772895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacology of glutamate receptor antagonists in the kindling model of epilepsy.
    Löscher W
    Prog Neurobiol; 1998 Apr; 54(6):721-41. PubMed ID: 9560847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The chemical biology of clinically tolerated NMDA receptor antagonists.
    Chen HS; Lipton SA
    J Neurochem; 2006 Jun; 97(6):1611-26. PubMed ID: 16805772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Failure of glycine site NMDA receptor antagonists to protect against L-2-chloropropionic acid-induced neurotoxicity highlights the uniqueness of cerebellar NMDA receptors.
    Widdowson PS; Gyte AJ; Upton R; Wyatt I
    Brain Res; 1996 Nov; 738(2):236-42. PubMed ID: 8955518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Excitoprotective effect of felbamate in cultured cortical neurons.
    Kanthasamy AG; Matsumoto RR; Gunasekar PG; Trunong DD
    Brain Res; 1995 Dec; 705(1-2):97-104. PubMed ID: 8821739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GlycineB antagonists and partial agonists in rodent models of Parkinson's disease--comparison with uncompetitive N-methyl-D-aspartate receptor antagonist.
    Karcz-Kubicha M; Lorenz B; Danysz W
    Neuropharmacology; 1999 Jan; 38(1):109-19. PubMed ID: 10193902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excitatory amino acid agonists and antagonists: pharmacology and therapeutic applications.
    Trist DG
    Pharm Acta Helv; 2000 Mar; 74(2-3):221-9. PubMed ID: 10812962
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Competitive Gly/NMDA receptor antagonists.
    Catarzi D; Colotta V; Varano F
    Curr Top Med Chem; 2006; 6(8):809-21. PubMed ID: 16719819
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical experience with excitatory amino acid antagonist drugs.
    Muir KW; Lees KR
    Stroke; 1995 Mar; 26(3):503-13. PubMed ID: 7886734
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 2,3-Dihydro-6,7-dichloro-pyrido[2,3-b]pyrazine-8-oxide as selective glycine antagonist with in vivo activity.
    Micheli F; Cugola A; Donati D; Missio A; Pecunioso A; Reggiani A; Tarzia G
    Bioorg Med Chem; 1997 Dec; 5(12):2129-32. PubMed ID: 9459010
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of strychnine-insensitive glycine receptor ligands in rats discriminating dizocilpine or phencyclidine from saline.
    Witkin JM; Steele TD; Sharpe LG
    J Pharmacol Exp Ther; 1997 Jan; 280(1):46-52. PubMed ID: 8996180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dantrolene antagonizes the glycineB site of the NMDA receptor.
    Salinska E; Sobczuk A; Lazarewicz JW
    Neurosci Lett; 2008 Feb; 432(2):137-40. PubMed ID: 18191027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel glycineB antagonists show neuroprotective activity in vivo.
    Wenk GL; Baker LM; Hauss-Wegrzyniak B; Danysz W; Stoehr JD
    Amino Acids; 1998; 14(1-3):223-6. PubMed ID: 9871465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. L-687,414, a low efficacy NMDA receptor glycine site partial agonist in vitro, does not prevent hippocampal LTP in vivo at plasma levels known to be neuroprotective.
    Priestley T; Marshall GR; Hill RG; Kemp JA
    Br J Pharmacol; 1998 Aug; 124(8):1767-73. PubMed ID: 9756395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroprotective effect of NMDA receptor glycine recognition site antagonism persists when brain temperature is controlled.
    Takaoka S; Bart RD; Pearlstein R; Brinkhous A; Warner DS
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):161-7. PubMed ID: 9040495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The glycine site of the NMDA receptor--five years on.
    Kemp JA; Leeson PD
    Trends Pharmacol Sci; 1993 Jan; 14(1):20-5. PubMed ID: 8382885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.